SIR-Spheres® 90Y Microspheres Treatment of Uveal Melanoma Metastasized to

See also
Status	Clinical Trial	Phase
Completed	`NCT01961115` - Epacadostat and Vaccine Therapy in Treating Patients With Stage III-IV Melanoma	Phase 2
Terminated	`NCT02359851` - Pembrolizumab in Treating Patients With Advanced Uveal Melanoma	Phase 2
Active, not recruiting	`NCT01143402` - Temozolomide or Selumetinib in Treating Patients With Metastatic Melanoma of the Eye	Phase 2

See also

Status

Clinical Trial

Phase

Completed

NCT01961115 - Epacadostat and Vaccine Therapy in Treating Patients With Stage III-IV Melanoma

Phase 2

Terminated

NCT02359851 - Pembrolizumab in Treating Patients With Advanced Uveal Melanoma

Phase 2

Active, not recruiting

NCT01143402 - Temozolomide or Selumetinib in Treating Patients With Metastatic Melanoma of the Eye

Phase 2

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT01473004
Study type	Interventional
Source	Thomas Jefferson University
Contact
Status	Active, not recruiting
Phase	Phase 2
Start date	October 31, 2011
Completion date	December 31, 2023

SIR-Spheres® 90Y Microspheres Treatment of Uveal Melanoma Metastasized to Liver

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms